Author archives: Spandan Khandelwal

The U.S. market came back in July and early August owing to a robust job market, strong corporate earnings, and a slight decline in inflation. However, the Fed’s hawkish stance…

The stock market is expected to remain under pressure as inflation still remains elevated, which could prompt the Federal Reserve to raise interest rates aggressively. Therefore, we think it could…

Minerva Neurosciences (NERV) and Vertex Pharmaceuticals (VRTX) are expected to benefit from the rising number of chronic diseases and continued technological advancements in the industry. Since NERV has gained more…

Since inflation is still hovering around 40-year highs, the Fed will likely maintain its hawkish stance, which could keep the market under pressure. Therefore, it could be wise to invest…

Axsome Therapeutics (AXSM) and Johnson & Johnson (JNJ) are expected to benefit from the rising number of chronic diseases and continued technological advancements in the pharmaceutical sector. But which of…

Rapid technological progress and growing 5G deployment should bode well for the entertainment industry. However, we think it could be wise to avoid fundamentally weak stocks Warner Bros. (WBD), Chicken…

Increasing smartphone penetration and rising technological advancements have driven the gaming and gambling industry’s growth. While DraftKings (DKNG) is expected to benefit from increasing inclination toward online gaming, Boyd Gaming…

The S&P 500 and the Nasdaq closed the last week lower, ending the four-week winning streak on concerns over the hawkish Fed and weak economic data of some of the…

Shares of the camera and social media company Snap Inc. (SNAP) have plunged 73.3% year-to-date due to the broader tech sell-off and the company’s weak operating performance. Given the company’s…

Though inflation has declined slightly from the multi-decade high level, the Federal Reserve’s intention to keep raising interest rates until price increases return to its target level could keep the…